You are here: Welcome » Rochelle Walensky

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
rochelle_walensky [2023/05/13 02:28]
liam [Research]
rochelle_walensky [2023/05/13 03:42] (current)
liam
Line 3: Line 3:
 {{ ::rochelle_walensky.png?200|}} {{ ::rochelle_walensky.png?200|}}
  
-Dr. **Rochelle Walensky** is an American public health official based in [[united_states:Washington, D.C.]] She serves as the Director of the [[Centers for Disease Control and Prevention]] (CDC).+Dr. **Rochelle Walensky** is an American public health official based in [[united_states:Washington, D.C.]] She serves as the Director of the [[Centers for Disease Control and Prevention]] (CDC) and the administrator of the [[Agency for Toxic Substances and Disease Registry]] (ATSDR).((//New CDC Director.// (2021, January 20). Centers for Disease Control and Prevention. https://web.archive.org/web/20230429141836/https://www.cdc.gov/media/releases/2021/s0120-rochelle-walensky.html))
  
 According to her profile on the [[Harvard T.H. Chan School of Public Health]]’s [[Prevention Policy Modeling Lab]] website, Walensky has been “internationally recognized for motivating US policy toward the promotion of routine [[HIV]] screening and for her work on effective and efficient strategies of HIV care in [[africa:South Africa]].”((//Rochelle Walensky.// Prevention Policy Modeling Lab. Retrieved February 2, 2023, from https://web.archive.org/web/20230202190315/https://prevention-policy-modeling-lab.sph.harvard.edu/rochelle-walensky/)) According to her profile on the [[Harvard T.H. Chan School of Public Health]]’s [[Prevention Policy Modeling Lab]] website, Walensky has been “internationally recognized for motivating US policy toward the promotion of routine [[HIV]] screening and for her work on effective and efficient strategies of HIV care in [[africa:South Africa]].”((//Rochelle Walensky.// Prevention Policy Modeling Lab. Retrieved February 2, 2023, from https://web.archive.org/web/20230202190315/https://prevention-policy-modeling-lab.sph.harvard.edu/rochelle-walensky/))
Line 41: Line 41:
 ==== Conflicts of Interest ==== ==== Conflicts of Interest ====
  
-It has been reported that Walensky's husband, [[Loren Walensky]], co-founded [[pharmaceutical_companies:Lytica Therapeutics]] in October2019, and quickly received millions of dollars in HHS grants.((August 6, 2021 RedState | [[https://redstate.com/scotthounsell/2021/08/06/exclusive-cdc-director-walenskys-husband-received-5-million-in-hhs-grants-and-thats-just-the-start-of-it-n421809|EXCLUSIVECDC Director Walensky's Husband Received $5 Million in HHS Grants - and That'Just the Start of It]]))+Walensky's husband, [[Loren Walensky]], co-founded [[pharmaceutical_companies:Lytica Therapeutics]] in October 2019. The company received a grant for up to $16.9 million from the [[United States Department of Health and Human Services]] (HHS) in February 2020, for a project to "develop antibacterial peptides with broad activity against multidrug-resistant bacteria."((HounsellS. (2021, August 6). //EXCLUSIVE: CDC Director Walensky’s Husband Received $5 Million in HHS Grants - and That’s Just the Start of It.// RedState. https://web.archive.org/web/20230110204450/https://redstate.com/scotthounsell/2021/08/06/exclusive-cdc-director-walenskys-husband-received-5-million-in-hhs-grants-and-thats-just-the-start-of-it-n421809)) ((Robinson, J., & Finnegan, A. (2020, April 18). //CARB-X funds Lytica Therapeutics to develop antibacterial peptides to treat drug-resistant infections in the lungs and other parts of the body.// CARB-X. http://archive.today/2021.08.08-003713/https://carb-x.org/carb-x-news/carb-x-funds-lytica-therapeutics-to-develop-antibacterial-peptides-to-treat-drug-resistant-infections-in-the-lungs-and-other-parts-of-the-body/))  
 + 
 +The specific funding program in question, the [[Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator]] (CARB-X), is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria. If Walensky’Lytica Therapeutics is tasked with developing new antibiotic products to treat lung infections (like [[pneumonia]]), it stands to reason that the use of the many existing [[antibiotics]] and repurposed drugs like [[ivermectin]] would stand in the way of them fulfilling their CARB-X grant obligations.((Sturgess, L. (2023, May 12). //Deer in the Headlights.// Substack; Rounding the Earth. http://archive.today/2023.05.13-003339/https://liamsturgess.substack.com/p/deer-in-the-headlights)) This is particularly notable given the apparent role of [[bacterial pneumonia]] in a significant portion of deaths attributed to [[COVID-19]] during Walensky's term as CDC director.((Paul, M. (2023, May 5). //Secondary Bacterial Pneumonia Drove Many COVID-19 Deaths.// Northwestern University Feinberg School of Medicine. http://archive.today/2023.05.11-193941/https://news.feinberg.northwestern.edu/2023/05/05/secondary-bacterial-pneumonia-drove-many-covid-19-deaths/)) 
 + 
 +===== External links ===== 
 + 
 +  * [[https://en.wikipedia.org/wiki/Rochelle_Walensky|Wikipedia]] 
 +  * [[https://wikispooks.com/wiki/Rochelle_Walensky|Wikispooks]]
Back to top